Article
Evaluating NAT2PRED for inferring the individual acetylation status from unphased genotype data.
BMC medical genetics - 31 Dec 2009
Sabbagh Audrey, Darlu Pierre, Vidaud Michel
Abstract excerpt
BACKGROUND: Genetically determined differences in N-acetylation capacity have proved to be important determinants of both the effectiveness of therapeutic response and the development of adverse drug reactions and toxicity during drug treatment. NAT2PRED is a web-server that allows a fast determi...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
